153 related articles for article (PubMed ID: 24396477)
1. Detection of circulating vascular endothelial growth factor and matrix metalloproteinase-9 in non-small cell lung cancer using Luminex multiplex technology.
Zhang Y; Wu JZ; Zhang JY; Xue J; Ma R; Cao HX; Feng JF
Oncol Lett; 2014 Feb; 7(2):499-506. PubMed ID: 24396477
[TBL] [Abstract][Full Text] [Related]
2. The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer.
Tamura M; Oda M; Matsumoto I; Tsunezuka Y; Kawakami K; Ohta Y; Watanabe G
Ann Surg Oncol; 2004 Oct; 11(10):928-33. PubMed ID: 15383417
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) serum levels in patients with metastatic non-small cell lung cancer (NSCLC).
Laack E; Scheffler A; Burkholder I; Boeters I; Andritzky B; Schuch G; Görn M; Vohwinkel G; Edler L; Fiedler W; Hossfeld DK
Lung Cancer; 2005 Oct; 50(1):51-8. PubMed ID: 15992959
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and prognostic significance of serum MMP-9, endostatin and VEGF in patients with advanced non-small cell lung cancer].
Li X; Li B; Lai B; Zhang X; Ge Q; Zhan X; Wang Y; Zhu Y
Zhongguo Fei Ai Za Zhi; 2007 Apr; 10(2):138-40. PubMed ID: 21114938
[TBL] [Abstract][Full Text] [Related]
5. [Clinical research of perioperative serum VEGF and MMP-9 levels in patients with non-small cell lung cancer.].
Hu Y; Li B; Song C
Zhongguo Fei Ai Za Zhi; 2008 Oct; 11(5):734-8. PubMed ID: 20738923
[TBL] [Abstract][Full Text] [Related]
6. Detection of serum VEGF and MMP-9 levels by Luminex multiplexed assays in patients with breast infiltrative ductal carcinoma.
Zhang J; Yin L; Wu J; Zhang Y; Xu T; Ma R; Cao H; Tang J
Exp Ther Med; 2014 Jul; 8(1):175-180. PubMed ID: 24944618
[TBL] [Abstract][Full Text] [Related]
7. [Expressions of vascular endothelial growth factor C and matrix metalloproteinases-2 and prognosis of non-small cell lung carcinoma].
Zhang HZ; Wei YP; Li HG; Wang M; Liu JG; Wu C
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1307-10. PubMed ID: 16982442
[TBL] [Abstract][Full Text] [Related]
8. [Changes in serum vascular endothelial growth factor and matrix metalloproteinase-9 after video-assisted thoracoscopic surgery and thoracotomic Lobectomy in the treatment of patients with non-small cell lung cancer].
Tian W; Tong H; Sun Y; Wu Q; Ma C; Jiao P
Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):24-9. PubMed ID: 24398310
[TBL] [Abstract][Full Text] [Related]
9. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.
Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP
J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607
[TBL] [Abstract][Full Text] [Related]
10. Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer.
Lin SY; Wang YY; Sheu WH
Clin Endocrinol (Oxf); 2003 Apr; 58(4):513-8. PubMed ID: 12641636
[TBL] [Abstract][Full Text] [Related]
11. Presurgical serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinoma.
Liu CJ; Chang KW; Lin SC; Cheng HW
Oral Oncol; 2009 Oct; 45(10):920-5. PubMed ID: 19502103
[TBL] [Abstract][Full Text] [Related]
12. Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer.
Shou Y; Hirano T; Gong Y; Kato Y; Yoshida K; Ohira T; Ikeda N; Konaka C; Ebihara Y; Zhao F; Kato H
Br J Cancer; 2001 Nov; 85(11):1706-12. PubMed ID: 11742492
[TBL] [Abstract][Full Text] [Related]
13. Significance of MMP-9 and VEGF-C expression in North Indian women with breast cancer diagnosis.
Thammineni KL; Thakur GK; Kaur N; Banerjee BD
Mol Cell Biochem; 2019 Jul; 457(1-2):93-103. PubMed ID: 30993496
[TBL] [Abstract][Full Text] [Related]
14. Serum VEGF levels in the early diagnosis and severity assessment of non-small cell lung cancer.
Lai Y; Wang X; Zeng T; Xing S; Dai S; Wang J; Chen S; Li X; Xie Y; Zhu Y; Liu W
J Cancer; 2018; 9(9):1538-1547. PubMed ID: 29760791
[No Abstract] [Full Text] [Related]
15. [Association of JMJD3, MMP-2 and VEGF expressions with clinicopathological features of invasive ductal breast carcinoma].
Xu X; Wang J; Yan C; Men Y; Jiang H; Fang H; Xu X; Yang J
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Nov; 40(11):1593-1600. PubMed ID: 33243732
[TBL] [Abstract][Full Text] [Related]
16. [Overexpression of IL-8 and MMP-9 confer high malignant phenotype in patients with non-small cell lung cancer].
Liu Z; Xu S; Xiao N; Song C; Zhang H; Li F
Zhongguo Fei Ai Za Zhi; 2010 Aug; 13(8):795-802. PubMed ID: 20704821
[TBL] [Abstract][Full Text] [Related]
17. Correlations of serum VEGF and MMP-2 levels with CLM in CRC patients and effects of TACE on their expressions.
Xu H; Ren YJ; Liu K; Min XL; Yang L; Zhou Y; Zheng J; Yang C
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3394-3401. PubMed ID: 29917190
[TBL] [Abstract][Full Text] [Related]
18. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.
Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB
Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608
[TBL] [Abstract][Full Text] [Related]
19. The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer.
Lu CL; Ji Y; Ge D; Guo J; Ding JY
Dis Esophagus; 2011 May; 24(4):283-90. PubMed ID: 21087342
[TBL] [Abstract][Full Text] [Related]
20. Protein expression and significance of VEGF, EGFR and MMP-9 in non-small cell lung carcinomas.
Jin Y; Li JP; Tang LY; Chen JN; Feng ZY; Liu Y; Zhou J; Shao CK
Asian Pac J Cancer Prev; 2011; 12(6):1473-6. PubMed ID: 22126484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
